Climate change should make it possible to grow soya bean profitably in the UK, as far north as the Scottish border by 2050, according to a new study from the UK’s Rothamsted Research. Read more in C&I Magazine.
Smoking cessation drug cytisine reduces the loss of a type of nerve cell in the brains of female mice. The findings provide evidence for the use of the drug to treat Parkinson’s disease (PD) or stop its progression in women, say researchers. Read more in C&I Magazine.
A therapy based on CRISPR gene editing technology appears to stop replication of viruses responsible for both flu and Covid-19. The therapy could be delivered directly to the lungs using a nebuliser, making it easy for patients to use at home. Read more in C&I Magazine.
For many in non-scientific industries, it might be simple enough to carry on working with the addition of Zoom and Google Docs to keep workflows running smoothy, however, for those in scientific, evidence-based industries, where the collection, structuring and sharing of data is vital, the impact has been more complex and challenging, highlighting concerns about the long-term viability of our industry in its current state.
Advances in technology are paving the way to reduce and potentially replace toxicity and drug safety testing in animals, Katrina Megget reports. Read the feature in C&I Magazine.
Organic chemistry highlights by G. Richard Stephenson, University of East Anglia, UK for March 2021.
The UFI serves as a unique recipe identifier and helps with the exact identification of a dangerous mixture to enable faster first aid.
Solar-powered cars are creeping towards commercial reality, while researchers continue to develop photovoltaic concepts that could find their way into future vehicles. Lou Reade reports. Read the full feature story in C&I Magazine.
Plant nanocellulose shows potential for use as nanocomposites, biomedical products, food coatings and more. It may also in future offer a lightweight alternative to steel and plastic for car bodies, Maria Burke reports. Read the full feature in C&I Magazine.
Karl H. Lauri explains how ERP/MRP gives smaller pharma and biotech suppliers the backbone necessary to give the resilience required today. Read the feature in full in C&I Magazine.